The increasing number of sophisticated molecules entering today’s biologics-development pipeline can pose purification challenges during process development in the biopharmaceutical industry. Join Dr. Mark Snyder as he discusses scalable purification strategies from capture to polishing of these biomolecules. Case studies to design robust purification methods and increase overall bioprocessing efficiencies will be presented.

Topics Include:

• Hydrophobic anionic exchange mixed-mode resin, Nuvia aPrime 4A, designed for the purification of the diverse and expanding biotherapeutics
• Calcium affinity cation exchange mixed-mode media, CHT XT, fine-tuned for superior removal of aggregates and process impurities and virus purification
• High performance strong anion exchange resin, Nuvia HP-Q, engineered for large biomolecule purification like plasma proteins IgA and IgM, viruses and VLPs

Speaker:

Mark A. Snyder, Ph.D
R&D Manager, Process Chromatography Applications
Bio-Rad Laboratories